1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comment on "Microsatellite instability as a predictive biomarker for adjuvant chemotherapy in gastric cancer"
    Correspondence

    Mondaca, S.; Yoon, S. S.; Strong, V. E.; Ku, G. Y.; Ilson, D. H.; Greally, M.; Janjigian, Y. Y.
    Annals of Surgery (2019)

    Fulltext@MSK | Save
  • Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis
    Conference Paper

    Lentzsch, S.; Lagos, G. G.; Comenzo, R. L.; Zonder, J. A.; Pregja, S.; Osman, K.; Tsai, W. Y.; Landau, H.; Sanchorawala, V.
    Taylor & Francis Group (2019)

    Fulltext@MSK | Save
  • Emerging epigenetic-modulating therapies in lymphoma
    Review

    Sermer, D.; Pasqualucci, L.; Wendel, H. G.; Melnick, A.; Younes, A.
    Nature Reviews Clinical Oncology (2019)

    Fulltext@MSK | Save
  • TOX is a critical regulator of tumour-specific T cell differentiation
    Journal Article

    Scott, A. C.; Dündar, F.; Zumbo, P.; Chandran, S. S.; Klebanoff, C. A.; Shakiba, M.; Trivedi, P.; Menocal, L.; Appleby, H.; Camara, S.; more...
    Nature (2019)

    Fulltext@MSK | Save
  • Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia
    Review

    Branford, S.; Kim, D. D. H.; Apperley, J. F.; Eide, C. A.; Mustjoki, S.; Ong, S. T.; Nteliopoulos, G.; Ernst, T.; Chuah, C.; Gambacorti-Passerini, C.; more...
    Leukemia (2019)

    Fulltext@MSK | Save
  • Disruption of MAGI2-RapGEF2-Rap1 signaling contributes to podocyte dysfunction in congenital nephrotic syndrome caused by mutations in MAGI2
    Journal Article

    Zhu, B.; Cao, A.; Li, J.; Young, J.; Wong, J.; Ashraf, S.; Bierzynska, A.; Menon, M. C.; Hou, S.; Sawyers, C.; more...
    Kidney International (2019)

    Fulltext@MSK | Save
  • Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is associated with poor patient outcomes: A CIBMTR contemporary longitudinal study
    Journal Article

    Abidi, M. Z.; Hari, P.; Chen, M.; Kim, S.; Battiwala, M.; Dahi, P. B.; Diaz, M. A.; Gale, R. P.; Ganguly, S.; Gergis, U.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation
    Journal Article

    Ustun, C.; Young, J. A. H.; Papanicolaou, G. A.; Kim, S.; Ahn, K. W.; Chen, M.; Abdel-Azim, H.; Aljurf, M.; Beitinjaneh, A.; Brown, V.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Standard antithymocyte globulin dosing results in poorer outcomes in overexposed patients after ex vivo CD34(+) selected allogeneic hematopoietic cell transplantation
    Journal Article

    Scordo, M.; Bhatt, V.; Hilden, P.; Smith, M.; Thoren, K.; Cho, C.; Shah, G. L.; Maloy, M. A.; Papadopoulos, E. B.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Cost-effectiveness of a 24-month fixed duration of venetoclax in combination with rituximab in relapsed or refractory chronic lymphocytic leukemia in the United States
    Meeting Abstract

    Huntington, S. F.; Strunz-McKendry, T.; Masaquel, A. S.; Shapouri, S.; Sail, K.; Durno, N.; Mato, A.
    Value in Health (2019)

    Fulltext@MSK | Save